Literature DB >> 30878964

Vitamin D and vitamin B12 deficiencies in patients with small intestinal carcinoid tumour: is opioid use disorder a confounding factor in the diagnosis?

Richard Fagan1, Syed Sabeeh Najam Bokhari1, Faisal Inayat2.   

Abstract

Carcinoid tumours have the ability to secrete various peptides and bioamines that lead to carcinoid syndrome manifested as cutaneous flushing, diarrhoea, bronchial constriction and cardiac involvement. The deficiencies of vitamins D and B12 have previously been reported in patients with carcinoid tumours presumably due to chronic diarrhoea associated with the carcinoid syndrome. Herein, we chronicle the case of a patient with opioid use disorder who presented with small bowel obstruction that was found to be caused by a midgut carcinoid tumour. Laboratory studies revealed deficiencies of vitamins D and B12 even though he denied diarrhoea and had no other aetiology of deficiencies of these vitamins. Additionally, this paper presents a review of the published medical literature pertaining to clinical features, diagnostic investigations and treatment of intestinal carcinoid tumours and explores possible explanations for the observed deficiencies in these patients. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gastroenterology; general practice / family medicine; malabsorption; small intestine cancer; vitamins and supplements

Mesh:

Year:  2019        PMID: 30878964      PMCID: PMC6424257          DOI: 10.1136/bcr-2018-227430

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  29 in total

Review 1.  Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis.

Authors:  S B Jung; V Nagaraja; A Kapur; G D Eslick
Journal:  Intern Med J       Date:  2015-04       Impact factor: 2.048

2.  Management of gastrointestinal carcinoid tumours - 10 years experience at a district general hospital.

Authors:  Shridhar S Dronamraju; Vickram B Joypaul
Journal:  J Gastrointest Oncol       Date:  2012-06

3.  Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations.

Authors:  Helen L Robbins; Megan Symington; Barbara Mosterman; Josie Goodby; Louise Davies; Georgios K Dimitriadis; Gregory Kaltsas; Harpal S Randeva; Martin O Weickert
Journal:  Nutr Cancer       Date:  2018-05-21       Impact factor: 2.900

4.  Carcinoid syndrome from small bowel endocrine carcinoma in the absence of hepatic metastasis.

Authors:  Sayan Datta; Nigel Williams; Sari Suortamo; Asif Mahmood; Colin Oliver; Nicholas Hedley; Pijush Ray
Journal:  Age Ageing       Date:  2011-09-07       Impact factor: 10.668

Review 5.  Vitamin B12 deficiency.

Authors:  Robert Oh; David L Brown
Journal:  Am Fam Physician       Date:  2003-03-01       Impact factor: 3.292

Review 6.  Surgical Treatment of Small Bowel Neuroendocrine Tumors.

Authors:  Heather A Farley; Rodney F Pommier
Journal:  Hematol Oncol Clin North Am       Date:  2015-10-24       Impact factor: 3.722

Review 7.  Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.

Authors:  David S Klimstra
Journal:  Semin Oncol       Date:  2013-02       Impact factor: 4.929

8.  Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy.

Authors:  Liesbeth M Veenendaal; Inne H M Borel Rinkes; Cornelis J M Lips; Richard van Hillegersberg
Journal:  World J Surg Oncol       Date:  2006-06-26       Impact factor: 2.754

9.  Regional Gastrointestinal Transit Times in Patients With Carcinoid Diarrhea: Assessment With the Novel 3D-Transit System.

Authors:  Tine Gregersen; Anne-Mette Haase; Vincent Schlageter; Henning Gronbaek; Klaus Krogh
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

10.  Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.

Authors:  Sheharyar A Qureshi; Nicola Burch; Maralyn Druce; John G Hattersley; Saboor Khan; Kishore Gopalakrishnan; Catherine Darby; John L H Wong; Louise Davies; Simon Fletcher; William Shatwell; Sharmila Sothi; Harpal S Randeva; Georgios K Dimitriadis; Martin O Weickert
Journal:  BMJ Open       Date:  2016-05-04       Impact factor: 2.692

View more
  2 in total

1.  Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?

Authors:  Yejoo Jeon; David Leung; Claire A Lis; Hanlin L Wang; Corinne Deurdulian; Mark Mandelkern; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2021-03-30       Impact factor: 3.199

2.  Primary hepatic neuroendocrine tumour masquerading as a giant haemangioma: an unusual presentation of a rare disease.

Authors:  Talal Almas; Faisal Inayat; Maryam Ehtesham; Muhammad Kashif Khan
Journal:  BMJ Case Rep       Date:  2020-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.